Metabolic adaptation to intermittent fasting is independent of peroxisome proliferator-activated receptor alpha

被引:23
|
作者
Li, Guolin [1 ,2 ,3 ]
Brocker, Chad N. [1 ]
Yan, Tingting [1 ]
Xie, Cen [1 ]
Krausz, Kristopher W. [1 ]
Xiang, Rong [4 ,5 ]
Gonzalez, Frank J. [1 ]
机构
[1] NCI, Lab Metab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
[2] Hunan Normal Univ, Coll Life Sci, Lab Aging Biochem, Changsha 410081, Hunan, Peoples R China
[3] Hunan Normal Univ, Coll Life Sci, Minist Educ, Key Lab Prot Chem & Dev Biol, Changsha 410081, Hunan, Peoples R China
[4] Cent S Univ, State Key Lab Med Genet, Changsha 41001, Hunan, Peoples R China
[5] Cent S Univ, Sch Life Sci, Changsha 41001, Hunan, Peoples R China
来源
MOLECULAR METABOLISM | 2018年 / 7卷
基金
美国国家卫生研究院;
关键词
PPARA; PPARalpha; Intermittent fasting; Every-other-day fasting; Steatosis; Adaptive fasting response; FATTY-ACID OXIDATION; PPAR-ALPHA; HEPATIC STEATOSIS; LIVER-DISEASE; LIPID-METABOLISM; MICE; PHYSIOLOGY; MOUSE; MODEL; OBESITY;
D O I
10.1016/j.molmet.2017.10.011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Peroxisome proliferator-activated receptor alpha (PPARA) is a major regulator of fatty acid oxidation and severe hepatic steatosis occurs during acute fasting in Ppara-null mice. Thus, PPARA is considered an important mediator of the fasting response; however, its role in other fasting regiments such as every-other-day fasting (EODF) has not been investigated. Methods: Mice were pre-conditioned using either a diet containing the potent PPARA agonist Wy-14643 or an EODF regimen prior to acute fasting. Ppara-null mice were used to assess the contribution of PPARA activation during the metabolic response to EODF. Livers were collected for histological, biochemical, qRT-PCR, and Western blot analysis. Results: Acute fasting activated PPARA and led to steatosis, whereas EODF protected against fasting-induced hepatic steatosis without affecting PPARA signaling. In contrast, pretreatment with Wy-14,643 did activate PPARA signaling but did not ameliorate acute fasting-induced steatosis and unexpectedly promoted liver injury. Ppara ablation exacerbated acute fasting-induced hypoglycemia, hepatic steatosis, and liver injury in mice, whereas these detrimental effects were absent in response to EODF, which promoted PPARA-independent fatty acid metabolism and normalized serum lipids. Conclusions: These findings indicate that PPARA activation prior to acute fasting cannot ameliorate fasting-induced hepatic steatosis, whereas EODF induced metabolic adaptations to protect against fasting-induced steatosis without altering PPARA signaling. Therefore, PPARA activation does not mediate the metabolic adaptation to fasting, at least in preventing acute fasting-induced steatosis. Published by Elsevier GmbH.
引用
收藏
页码:80 / 89
页数:10
相关论文
共 50 条
  • [31] Peroxisome Proliferator-Activated Receptor Alpha Expression Changes in Human Pregnant Myometrium
    Dong, Kun
    Zhang, Ming-Xiang
    Liu, Yuan
    Su, Xue-Lian
    Chen, Bin
    Zhang, Xiang-Li
    REPRODUCTIVE SCIENCES, 2013, 20 (06) : 654 - 660
  • [32] Hepatocyte peroxisome proliferator-activated receptor α regulates bile acid synthesis and transport
    Xie, Cen
    Takahashi, Shogo
    Brocker, Chad N.
    He, Shijun
    Chen, Li
    Xie, Guomin
    Jang, Katrina
    Gao, Xiaoxia
    Krausz, Kristopher W.
    Qu, Aijuan
    Levi, Moshe
    Gonzalez, Frank J.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2019, (10): : 1396 - 1411
  • [33] Salidroside Ameliorates Cardiomyocyte Hypertrophy by Upregulating Peroxisome Proliferator-Activated Receptor-α
    Gao, Hui
    Tian, Kunming
    Meng, Yichong
    Liu, Xueping
    Peng, Yingfu
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [34] The role and regulation of the peroxisome proliferator activated receptor alpha in human liver
    Kersten, Sander
    Stienstra, Rinke
    BIOCHIMIE, 2017, 136 : 75 - 84
  • [35] Selective Peroxisome Proliferator-Activated Receptor Alpha Modulators (SPPARMα) in the Metabolic Syndrome: Is Pemafibrate Light at the End of the Tunnel?
    Fruchart, Jean-Charles
    Hermans, Michel P.
    Fruchart-Najib, Jamila
    Kodama, Tatsuhiko
    CURRENT ATHEROSCLEROSIS REPORTS, 2021, 23 (01)
  • [36] The expression and role of peroxisome proliferator-activated receptor α in atherosclerosis
    Gao, Wen
    Xu, Wei
    Li, Hongli
    MOLECULAR MEDICINE REPORTS, 2013, 7 (03) : 862 - 868
  • [37] Role of Peroxisome Proliferator-Activated Receptor a in Diabetic Nephropathy
    Chung, Sungjin
    Park, Cheol Whee
    DIABETES & METABOLISM JOURNAL, 2011, 35 (04) : 327 - 336
  • [38] Peroxisome proliferator-activated receptors and the metabolic syndrome
    Bragt, M. C. E.
    Popeijus, H. E.
    PHYSIOLOGY & BEHAVIOR, 2008, 94 (02) : 187 - 197
  • [39] The peroxisome proliferator-activated receptor α (PPARα):: role in hepatocarcinogenesis
    Gonzalez, FJ
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2002, 193 (1-2) : 71 - 79
  • [40] Influence of peroxisome proliferator-activated receptor α on ubiquinone biosynthesis
    Turunen, M
    Peters, JM
    Gonzalez, FJ
    Schedin, S
    Dallner, G
    JOURNAL OF MOLECULAR BIOLOGY, 2000, 297 (03) : 607 - 614